PTPI - Rare Market Hours Announcement has this Listing Running Hard

2023-12-12 11:10:11 ET

DENVER, Colo., Dec 12, 2023 ( www.247marketnews.com )- Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) reported, this morning, that it finished a Human Factors Study, to assess the technology component developed to facilitate patient’s access to its erectile dysfunction drug, STENDRA® (avanafil), associated with the Company’s intended FDA application for prescription to OTC switch.

Petros Pharmaceuticals is trading at $1.36, up $0.20 (+17.24%), on 3.3M shares traded.

Its 52-week range is $0.9172 to $9.54. It pulled back after hitting $1.7787.

24/7 MARKET NEWS, INC Disclaimer

24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a …

The post Rare Market Hours Announcement has this Listing Running Hard appeared first on 24/7 Market News .

For further details see: